Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,721,086
-
Share change
-
+446,214
-
Total reported value
-
$339,520,199
-
Price per share
-
$23.17
-
Number of holders
-
71
-
Value change
-
+$11,482,867
-
Number of buys
-
44
-
Number of sells
-
35
Institutional Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q1 2015
As of 31 Mar 2015,
BELLICUM PHARMACEUTICALS INC - COM (BLCM) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,721,086 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, JENNISON ASSOCIATES LLC, FRANKLIN RESOURCES INC, venBio Select Advisor LLC, Redmile Group, LLC, and Point72 Asset Management, L.P..
This page lists
71
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.